| Basics |
Medicinova Inc
MediciNova Inc is a biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
|
| IPO Date: |
December 7, 2006 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$70.14M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 2.67%
|
| Avg Daily Range (30 D): |
$0.04 | 2.71%
|
| Avg Daily Range (90 D): |
$0.04 | 2.44%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.11M |
| Avg Daily Volume (30 D): |
.01M |
| Avg Daily Volume (90 D): |
.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
167 |
| Avg Trade Size (Sh.) (30 D): |
201 |
| Avg Trade Size (Sh.) (90 D): |
178 |
| Institutional Trades |
| Total Inst.Trades: |
63 |
| Avg Inst. Trade: |
$1.82M |
| Avg Inst. Trade (30 D): |
$.57M |
| Avg Inst. Trade (90 D): |
$.55M |
| Avg Inst. Trade Volume: |
.29M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.19M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
538.88K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
|
$-.06
|
$-.06
|
|
Diluted EPS
|
|
$-.06
|
$-.06
|
|
Revenue
|
$
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -2.86M
|
$ -2.85M
|
|
Operating Income / Loss
|
$
|
$ -3.2M
|
$ -3.31M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ -3.78M
|
$ M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 31, 2006:
1:10
|
|
